Akston Biosciences Corporation Revenue and Competitors

Beverly, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Akston Biosciences Corporation's estimated annual revenue is currently $13.8M per year.(i)
  • Akston Biosciences Corporation's estimated revenue per employee is $155,000

Employee Data

  • Akston Biosciences Corporation has 89 Employees.(i)
  • Akston Biosciences Corporation grew their employee count by 48% last year.

Akston Biosciences Corporation's People

NameTitleEmail/Phone
1
Quality Control ManagerReveal Email/Phone
2
Manager Quality Control EM and Material ControlReveal Email/Phone
3
Manager, Downstream Process DevelopmentReveal Email/Phone
4
Quality Control Scientist 1Reveal Email/Phone
5
Quality Assurance Associate IReveal Email/Phone
6
Staff Engineer Cell Culture Process DevelopmentReveal Email/Phone
7
Scientist IIReveal Email/Phone
8
Manager-Veterinary and Pharmacology ProjectsReveal Email/Phone
9
Quantitative Bioanalytics ScientistReveal Email/Phone
10
Senior Research AssociateReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.7M82-45%$107.3MN/A
#2
$0.2M1-50%N/AN/A
#3
$6.2M4021%N/AN/A
#4
$42.2M2184%$165MN/A
#5
$14.6M94-37%$312.8MN/A
#6
$0.3M2-67%N/AN/A
#7
$235M366-5%$340.9MN/A
#8
$56M289-7%$7.6MN/A
#9
$4.7M6136%N/AN/A
#10
$2M138%N/AN/A
Add Company

What Is Akston Biosciences Corporation?

Akston Biosciences Corporation is a leader in the field of insulin engineering.  The company was founded in 2011 by the former SmartCells, Inc. team who developed the world’s first clinical glucose-responsive insulin (acquired by Merck & Co. in 2010).  Combining its core expertise with modern biotechnology manufacturing techniques, Akston is developing new classes of biologic therapeutics for use in autoimmune Type 1 diabetes prevention, ultra-long acting insulin therapy, and oncology to dramatically improve both human and animal health.  The company has raised over $18 million in equity financing from the management team and private investors, as well as $10 million from the NIH and the Helmsley Charitable Trust.

keywords:N/A

N/A

Total Funding

89

Number of Employees

$13.8M

Revenue (est)

48%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15M89-7%N/A
#2
$15M93-3%N/A
#3
$23.3M9322%N/A
#4
$14.6M9411%N/A
#5
$7.5M10921%N/A